Blog

Risperdal

Arkansas Supreme Court Takes Different View of Risperdal Fraud Case

Late last year, the federal Department of Justice settled a long-running dispute with drug maker Johnson & Johnson over allegations of the off-label marketing of the anti-psychotic drug Risperdal. As is often the case, Johnson & Johnson also faced several state False Claims Act and Deceptive Trade Practices Act allegations, as Medicaid and Medicare funding [...]

By | 2018-08-21T14:41:01+00:00 April 9th, 2014|Healthcare Fraud|